CBYI Financials 07/15/2014 21:33:43
Cal-Bay International,
CBYI Financials 07/15/2014 21:33:43
Cal-Bay International, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - 7 3
Cost of Revenue - - - -
Gross Profit - - 7 3
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 302 75 4 57
Non-Recurring Items - - - -
Other 407 - - -
Operating Income (709) (75) 2 (54)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (709) (75) 2 (54)
Interest Expense - - - -
Earnings Before Tax (709) (75) 2 (54)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (709) (75) 2 (54)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (709) (75) 2 (54)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (709) (75) 2 (54)
Cal-Bay International Inc (CBYI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...
Continue Reading
Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...
Continue Reading
Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...
Continue Reading
Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...
Continue Reading
Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...
Continue Reading